European Pharmaceutical Review

JULY 4, 2024

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. The MA pathway is applicable for herbal medicines designed to treat more serious health conditions and require a medical prescription or the supervision of a medical practitioner. 2012/1916).

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

World of DTC Marketing

MAY 13, 2021

One study analyzed the drug ads of an anti-hypertensive drug in 210 issues of the NEJM between 1985 to 1996 and showed increased ad frequency was associated with an increase in prescriptions. Manhatten Research Taking The Pulse 2017. 2017 study. But there are also warnings. But what about online? Medscape reaches over 3.6

Physicians 173

Physicians Marketing Drug Sample Pharma 173

MedCity News

JUNE 12, 2023

Bringing the very first prescription digital therapeutic (PDT) to market in 2017, Pear Therapeutics went above and beyond to follow suggested regulatory guidelines, obtained Food & Drug Administration (FDA) clearance, and provided solid clinical study evidence. Photo: Bulat Silvia, Getty Images

Food and Drug Administration 91

Food and Drug Administration Prescription Government FDA 91

pharmaphorum

JANUARY 5, 2023

Addiction treatment specialist Spero Health has expanded an agreement to use Pear Therapeutics’ prescription digital therapeutics (DTx) in its network of US clinics. million in the third quarter, with predictions that it will make between $14 million and $16 million from its prescription DTx range for the full year. billion.

Prescription 52

Prescription Specialization FDA Networking 52

World of DTC Marketing

MAY 19, 2021

The increase followed total Humira price hikes of 19 percent during 2017 and 2018. The cost of Humira, which is injected via syringe, was more than $72,000 a year on prescription drug websites this week and is not expected to come down until at least 2023.

Pharma 181

Pharma Prescription Patients Pharmaceutical 181

World of DTC Marketing

JUNE 27, 2021

But, will physicians tell patients that results depend on lifestyle intervention and a low-calorie diet? We are an obese country, and diabetes is getting worse.

Side effects 194

Side effects Patients Insurance Doctors 194

World of DTC Marketing

MAY 24, 2022

Cerebral will stop writing prescriptions for Adderall, Ritalin, and other controlled substances to new ADHD patients as concerns grow about telehealth companies’ prescribing practices. A body of work published since 2017 suggests that these apps work best when combined with in-person therapy.

Patients 252

Patients Prescription Medical Marketing 252

PM360

OCTOBER 22, 2024

They become supportive extensions of the brand that work on a personalized level with patients and care teams, from the moment the prescription is written to other important points along the treatment journey. Even straightforward interactions like the initial prescription can be cluttered with unnecessary overlap and misalignment.

Patients 59

Patients Healthcare Provider Pharma Prescription 59

pharmaphorum

NOVEMBER 2, 2022

The struggle to manage pain for individuals has been one that goes back a long way in history, with one of the earliest recorded medical prescriptions being for opium. Ben Hargreaves discovers how chronic pain could be a key area for digital therapeutics, as they offer non-addictive and effective relief from the condition.

Food and Drug Administration 131

Food and Drug Administration Food Patients FDA 131

pharmaphorum

JULY 15, 2022

Things became litigious in 2017, when a Delaware court found that Teva’s label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK’s RE40,000 patent, which was reissued by the Patent and Trademark Office (PTO) in 2008.

Prescription 52

Prescription Doctors Government Marketing 52

PM360

AUGUST 29, 2022

Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Xyzal —which launched in 1995 but entered the OTC market in 2017—found success with a creative that debuted in February. Affordability is key for Rx advertisers.

Pharma 98

Pharma Prescription Marketing Pharmaceutical Sales 98

World of DTC Marketing

JANUARY 21, 2021

SUMMARY: Among US adults who looked for health information and used the internet for their most recent search, the percentage who reported accessing health information without frustration was stable during the study period (from 37.2% in 2008 to 38.5%

Pharma 180

Pharma Sales tools Medical Media 180

Clarivate

FEBRUARY 28, 2023

Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021. 9; 9/2017; p447; DOI:10.1016/j.je.2017.02.001 ” Graefe’s Archive for Clinical and Experimental Ophthalmology; V.259;

Prescription 98

Prescription Patients Pharmacology Healthcare 98

pharmaphorum

SEPTEMBER 30, 2022

The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year.

FDA 86

FDA Doctors Patients Prescription 86

Clarivate

MAY 11, 2023

Mainland China has streamlined regulatory protocols for testing and approving prescription drugs in recent years, making dozens of urgently needed treatments, from domestic and international manufacturers alike, available to patients in the process. 3] First list of overseas new drugs urgently needed in clinical practice , November 2018. [4]

Marketing 52

Marketing Patients Management Insurance 52

PM360

DECEMBER 20, 2023

From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6% Between 2017 and 2021, the median time difference between the first global approval and the approval in China was five years 1. Long Way to Go: Progress of Orphan Drug Accessibility in China from 2017 to 2022.”

Marketing 105

Marketing Insurance Medical Manufacturing 105

PM360

NOVEMBER 21, 2022

Over recent years, the pharmacy has evolved from merely the point of filling a prescription to a highly frequented healthcare destination. Centers for Disease Control and Prevention, November 16, 2017. The pharmacy is no longer simply the last stop on a patient’s healthcare journey.

Marketing 52

Marketing Education Retail Prescription 52

European Pharmaceutical Review

APRIL 21, 2023

The Stockholm region in Sweden attempted this by developing a “Wise List” of medicines between 2017 and 2021, which enables physicians to select the least environmentally harmful product from those with equivalent efficacy. Climate-conscious prescription of inhaled medicinal products. Internet] NHS England. cited 23Apr].

Pharma 98

Pharma Food and Drug Administration Medicine Pharmaceutical 98

PM360

JULY 21, 2022

Though 80% of healthcare providers (HCPs) identified as “rep-accessible” in 2008 (that is, willing to meet with over 70% of the sales reps who try to approach them), that number had decreased to 44% in 2017. Throughout the pandemic, physician access has become even more of a challenge. Increasing Market Awareness Remains a Challenge.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

European Pharmaceutical Review

JANUARY 25, 2024

It emphasises its ability to make information interoperable with electronic health systems such as e-prescription and electronic health records. 2017) “Danmark har flest smartphones i hele verden”, Berlingske, Eurostat (2022) “Medicine Use Statistics” European Commission. Article 63 EMA (29 January 2020).

Healthcare 98

Healthcare Healthcare Safety Electronics 98

World of DTC Marketing

MARCH 12, 2021

In a 2017 AARP study, the cost to Medicare of social isolation and loneliness was estimated at $6.7 Again, this is “general health content” and focuses more on prevention than treatment, but at some point in time, pharma has to look at ways to get closer to people beyond selling them s prescription. billion annually.

Physicians 181

Physicians Pharma Leads Prescription 181

PM360

NOVEMBER 27, 2023

Before you walk out of your doctor’s office with a new prescription, question if your drug has been studied in females and if there is anything females should be aware of. Nature 550, S18–S19 (2017). This will result not only in better care for you, but ultimately better science, better guidelines, and better care for everybody.

Healthcare 111

Healthcare Healthcare Medicine FDA 111

Pharmaceutical Technology

AUGUST 8, 2022

In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. The FDA has also cleared Akilii’s EndeavorRx , a prescription-only medical device for attention deficit hyperactivity disorder. Proteus’s profile grew considerably; it was soon valued at $1.5

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

pharmaphorum

DECEMBER 15, 2022

million NHS prescriptions per month delivered directly to people’s homes. Indeed, -between 2017 and 2021, the number of clinical trials initiated in the UK fell by 41%, significantly impacting the country’s global rankings. In short, some people simply want to manage their own health.

Consulting 84

Consulting Healthcare Healthcare Medicine 84

World of DTC Marketing

JULY 8, 2022

prescription drug sales signals that big pharma will do anything to avoid hurting profits. For several years, Humira was the best-selling prescription drug in the world.1 In AbbVie’s’ own words, “The changes made by the 2017 tax law altered U.S. taxation on foreign earnings for U.S.

Sales 269

Sales Prescription Pharma Manufacturing 269

Pharmaceutical Technology

JANUARY 6, 2023

In 2020, the Federal Trade Commission issued a report regarding settlements reached between brand and generic manufacturers in FY 2017 and noted that “for the first time since [FY] 2004, no settlement agreement in [FY] 2017 contains a no-[authorized generic] AG commitment.”.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

PM360

SEPTEMBER 15, 2022

Patient Pages: Patients Refuse Prescription Use After Recalls. adults are unlikely to use a prescription drug that has experienced a recall, regardless of whether that issue was fixed. Qualio surveyed 2,002 U.S. Discoveries & Innovations: Hormone Could Improve Cognition in Down Syndrome Patients.

Healthcare 52

Healthcare Healthcare Doctors Physicians 52

Pharmaceutical Technology

DECEMBER 4, 2022

In September 2017, Amgen announced that it reached a global settlement with AbbVie, scheduling Amjevita’s American launch for January 31, 2023. Temporary first-to-market advantage. Any potential first-to-market advantage is likely not going to last too long since Amjevita does not have the coveted interchangeability designation, says Bhat.

Marketing 104

Marketing Physicians Competition Patients 104

pharmaphorum

JULY 8, 2022

A report by the Senate Finance Committee has concluded that AbbVie exploited a financial loophole introduced by former President Donald Trump in 2017 to avoid paying “billions in taxes.” Last year – after the investigation got underway – it was recorded at 12.5%.

Sales 59

Sales Pharma Distribution Prescription 59

World of DTC Marketing

DECEMBER 14, 2021

According to the Mayo Clinic “The 3 main reasons cited by pharmaceutical companies for the high cost of new prescription drugs do not apply to insulin. In the five-yearperiodfrom2016to2020, pharmaceutical companies raised the prices of branded prescription drugs by 36%—almost four times the rate of inflation during that period.

Prescription 184

Prescription Pharma Marketing Competition 184

Clarivate

OCTOBER 17, 2024

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Such a change would sharply increase the number of people covered under this program.

Healthcare 52

Healthcare Healthcare Government Insurance 52